Figure 3.
Predicted 365 day hemoglobin by baseline hemoglobin for zidovudine and non-zidovudine-based cART regimens
Estimated mean hemoglobin response at 365 days with 95% confidence bands. Adjusted to female sex and cotrimoxazole use.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.